Table 1.
Recipient status | Naive | AntiHBc+ | AntiHBc+ | AntiHBc- |
AntiHBs- | AntiHBs+ | AntiHBs+ | ||
No prophylaxis | > 40% | 13% | < 2% | 10% |
With prophylaxis | 12% | < 4% | < 2% | < 2% |
High risk | Intermediate risk | Low risk | Intermediate risk |
Recipient status | Naive | AntiHBc+ | AntiHBc+ | AntiHBc- |
AntiHBs- | AntiHBs+ | AntiHBs+ | ||
No prophylaxis | > 40% | 13% | < 2% | 10% |
With prophylaxis | 12% | < 4% | < 2% | < 2% |
High risk | Intermediate risk | Low risk | Intermediate risk |